Yayınlar & Eserler

Yayın Ağı
Makaleler 4
Tümü (4)
SCI-E, SSCI, AHCI (2)
SCI-E, SSCI, AHCI, ESCI (2)
Scopus (4)

1. COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder.

Baba C., Kaya E., Ozcelik S., Ozdogar A. T., Samedzade U., Cevik S., et al.
Clinical neurology and neurosurgery , cilt.238, sa.238, ss.108152, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. What might the COVID-19 pandemic in regard to people with neuromyelitis optica spectrum disorder teach us regarding the future?

Baba C., Yavas I., SAMADZADE U., ÖZDOĞAR A. T., ÖZAKBAŞ S.
Clinical and Experimental Neuroimmunology , cilt.15, sa.1, ss.40-44, 2024 (Scopus) identifier

3. Is disease-modifying therapy use in multiple sclerosis a risk factor during the COVID-19 pandemic? A large cohort study

Ozakbas S., Baba C., Yavas I., SAMADZADE U., ÖZDOĞAR A. T.
Journal of Health Policy and Outcomes Research , cilt.2024, sa.1, ss.41-49, 2024 (Scopus) identifier

4. Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies.

Baba C., Ozcelik S., Kaya E., Samedzada U., Ozdogar A. T., Cevik S., et al.
Multiple sclerosis and related disorders , cilt.68, ss.104119, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. Comparison of the objective and subjective cognitive fatigue during relapse and remission in individuals with multiple sclerosis: preliminary results

Ozakbas S., Yigit P., Kara İ., Samadzade U., Özdoğar A. T.
40th Congress of The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Kobenhavn, Danimarka, 18 - 20 Eylül 2024, cilt.30, sa.3, (Özet Bildiri)

2. Epilepsy Prevalence and Characteristics in Patients with Multiple Sclerosis: Implications for Disease Management

Kaya E., Samadzade U., Ünal G., Zengin E. S., Ozakbas S.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.483-484, (Özet Bildiri) identifier

3. The Oligoclonal Band Dilemma: Decoding its Role in Predicting Relapsing-Remitting Multiple Sclerosis Progression

Baba C., ALIZADA S., Samadzade U., Cevik S., Yapici N., Simsek Y., et al.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, sa.3, ss.1207, (Özet Bildiri) identifier

4. Impact of Early Treatment Modification on Long-Term Outcomes in Treatment-Naive Multiple Sclerosis Patients: Adverse Reactions and Compliance Challenges

Samadzade U., Baba C., Simsek Y., Unal G. D., Kara I., ERTEKİN Ö., et al.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.1049, (Özet Bildiri) identifier

5. Determinants of Postpartum Relapse in Multiple Sclerosis: A Comprehensive Analysis of Demographic and Clinical Factors

ALIZADA S., Samadzade U., Yapici N., KAYA E., Özdoğar A. T., Ozakbas S.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, sa.3, ss.196-197, (Özet Bildiri) identifier

6. Baziller tepe sendromu: İki olgu sunumu

Samadzade U., Çiftçi L., Fırat A.
59. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 12 - 18 Aralık 2023, ss.109, (Tam Metin Bildiri)

7. Bladder dysfunction and associated factors in people with neuromyelitis optica spectrum disorder

Samadzade U., Yavaş I., Baba C., Özakbaş S.
ECTRIMS 2023, Milan, İtalya, 11 - 13 Ekim 2023, ss.675, (Özet Bildiri)

8. LİTYUM İNTOKSİKASYONUNA BAĞLI OLDUĞUNU DÜŞÜNDÜĞÜMÜZ BİR ENSEFALOPATİ OLGUSU

Samadzade U., Yaka E.
58. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 18 - 24 Kasım 2022, ss.416, (Özet Bildiri)

9. AKUT SEREBRAL İSKEMİ İLE AKUT MYOKARD ENFARKTÜSÜ BİRLİKTELİĞİ

Samadzade U., Suna Z., Öztürk V.
58. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 18 - 24 Kasım 2022, ss.304, (Özet Bildiri)

10. Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients

Ozakbas S., Baba C., SAMADZADE U., KAYA E., ÖZÇELİK S., Özdoğar A. T., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, sa.941, ss.776, (Özet Bildiri) Creative Commons License identifier
Metrikler

Yayın

16

Yayın (WoS)

7

Yayın (Scopus)

4

Atıf (WoS)

3

H-İndeks (WoS)

1

Atıf (Scopus)

4

H-İndeks (Scopus)

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları